We have recently developed a method to produce native human proinsulin using a bacterial expression system. A proinsulin fusion protein was recovered from inclusion bodies and cleaved using cyanogen bromide. The released proinsulin polypeptide was 5-sulfonated and purified by anion exchange Chromatograph). Following refolding, proinsulin was purified by reversed-phase high-performance liquid chromatography. Combined peptide mapping and mass spectrometric analysis indicated that the proinsulin contained the correct disulfide bridging pattern. This proinsulin will be used to study the specificity of the furin/PC family of converting enzymes by using it as a substrate in a recently developed assay.Key words: Proinsulin; Expression; Recombinant have generally been incomplete, presumably to protect proprietary interests [9,[12][13][14].We have developed a method which allows us to express proinsulin in bacteria by combining the procedures of both published and partially described, proprietary methods. In short, a fusion protein composed of an N-terminal polyhistidine affinity tag, a methionine residue, and the human proinsulin sequence was constructed in a bacterial expression vector. Following expression, proinsulin was cleaved from the polyhistidine tail, purified, and then refolded into its native state. The recombinant proinsulin was analyzed by mass spectrometry and peptide mapping to verify its identity and the formation of the correct disulfide bridging pattern. This recombinant proinsulin can be used in future studies for analyzing the specificity of PCI and PC2.